CLINICAL SIGNIFICANCE OF THE VEGFR-2 IN THE TUMORS AND BLOOD SERA OF THE BREAST CANCER PATIENTS

• Main Authors: E. A. Kim (Author), A. M. Platova (Author), I. V. Visotzkaya (Author), E. S. Gershteyn (Author), V. P. Letyagin (Author), N. E. Kushlinskiy (Author), E. E. Mironova (Author)
• Format: Book
• Published: ABV-press, 2014-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The analysis of the changes of the content of the angiogenic factor VEGFR-2 in the cytosol of the tumor and blood sera of the 30 breast can- cer patients determined by immunoenzyme method during neoadjuvant therapy is given. Likewise the correlation of this index with the main clinicomorphological c...